Multifunctional star-shaped polylactic acid implants for use in angioplasty

Star-shaped polylactic acids with different tacticity were synthesized and both polymers are capable of bestowing properties of anticoagulation and angiogenesis to their living host.</p

Effective Doses of Recombinant Human Bone Morphogenetic Protein-2 in Experimental Spinal Fusion

Study Design Nineteen dogs underwent L4-L5 intertransverse process fusions with either 58 μg, 115 μg, 230 μg, 460 μg, or 920 μg of recombinant human bone morphogenetic protein-2 carried by a polylactic acid polymer. A previous study (12 dogs) compared 2300 μg of recombinant human bone morphogenetic protein-2, autogenous iliac bone, and carrier alone in this model. All fusions subsequently were compared. Objectives To characterize the dose-response relationship of recombinant human bone morphogenetic protein-2 in a spinal fusion model. Summary of Background Data Recombinant osteoinductive morphogens, such as recombinant human bone morphogenetic protein-2, are effective in vertebrate diaphyseal defect and spinal fusion models. It is hypothesized that the quality of spinal fusion produced with recombinant human bone morphogenetic protein-2, above a threshold dose, does not change with increasing amounts of inductive protein. Methods After decortication of the posterior elements, the designated implants were placed along the intertransverse process space bilaterally. The fusion sites were evaluated after 3 months by computed tomography imaging, high-resolution radiography, manual testing, mechanical testing, and histologic analysis. Results As in the study using 2300 μg of recombinant human bone morphogenetic protein-2, implantation of 58–920 μg of recombinant human bone morphogenetic protein-2 successfully resulted in intertransverse process fusion in the dog by 3 months. This had not occurred in animals containing autograft or carrier alone. The cross-sectional area of the fusion mass and mechanical stiffness of the L4-L5 intersegment were not dose-dependent. Histologic findings varied but were not related to rhBMP-2 dose. Inflammatory reaction to the composite implant was proportional inversely to the volume of the fusion mass. Conclusions No mechanical, radiographic, or histologic differences in the quality of intertransverse process fusion resulted from a 40-fold variation in dose of recombinant human bone morphogenetic protein-2

Poly-l/dl-lactic acid films functionalized with collagen IV as carrier substrata for corneal epithelial stem cells

Limbal epithelial stem cells (LESCs) are responsible for the renewal of corneal epithelium. Cultivated limbal epithelial transplantation is the current treatment of choice for restoring the loss or dysfunction of LESCs. To perform this procedure, a substratum is necessary for in vitro culturing of limbal epithelial cells and their subsequent transplantation onto the ocular surface. In this work, we evaluated poly-L/DL-lactic acid 70:30 (PLA) films functionalized with type IV collagen (col IV) as potential in vitro carrier substrata for LESCs. We first demonstrated that PLA-col IV films were biocompatible and suitable for the proliferation of human corneal epithelial cells. Subsequently, limbal epithelial cell suspensions, isolated from human limbal rings, were cultivated using culture medium that did not contain animal components. The cells adhered significantly faster to PLA-col IV films than to tissue culture plastic (TCP). The mRNA expression levels for the LESC specific markers, K15, P63α and ABCG2 were similar or greater (significantly in the case of K15) in limbal epithelial cells cultured on PLA-col IV films than limbal epithelial cells cultured on TCP. The percentage of cells expressing the corneal (K3, K12) and the LESC (P63α, ABCG2) specific markers was similar for both substrata. These results suggest that the PLA-col IV films promoted LESC attachment and helped to maintain their undifferentiated stem cell phenotype. Consequently, these substrata offer an alternative for the transplantation of limbal cells onto the ocular surface.This work was supported by the Carlos III National Institute of Health, Spain (CIBER-BBN and Spanish Network on Cell Therapy, (TerCel RD12/0019/0036), MINECO/FEDER, EU), and the Castilla y León Regional Government, Spain (Regional Center for Regenerative Medicine and Cell Therapy, SAN673/VA/28/08 and SAN126/VA11/09)

Chopped basalt fibres: A new perspective in reinforcing poly(lactic acid) to produce injection moulded engineering composites from renewable and natural resources

This paper focuses on the reinforcing of Poly(lactic acid) with chopped basalt fibres by using silane treated and untreated basalt fibres. Composite materials with 5–10–15–20–30–40 wt% basalt fibre contents were prepared from silane sized basalt fibres using extrusion, and injection moulding, while composites with 5–10–15 wt% basalt fibre contents were also prepared by using untreated basalt fibres as control. The properties of the injection moulded composites were extensively examined by using quasi-static (tensile, three-point bending) and dynamic mechanical tests (notched and unnotched Charpy impact tests), dynamic mechanical analysis (DMA), differential scanning calorimetry (DSC), heat deflection temperature (HDT) analysis, dimensional stability test, as well as melt flow index (MFI) analysis and scanning electron microscopic (SEM) observations. It was found that silane treated chopped basalt fibres are much more effective in reinforcing Poly(lactic acid) than natural fibres; although basalt fibres are not biodegradable but they are still considered as natural (can be found in nature in the form of volcanic rocks) and biologically inert. It is demonstrated in this paper that by using basalt fibre reinforcement, a renewable and natural resource based composite can be produced by injection moulding with excellent mechanical properties suitable even for engineering applications. Finally it was shown that by using adequate drying of the materials, composites with higher mechanical properties can be achieved compared to literature data

Biodegradable Polylactic Acid (PLA) Microstructures for Scaffold Applications

In this research, we present a simple and cost effective soft lithographic process to fabricate PLA scaffolds for tissue engineering. In which, the negative photoresist JSR THB-120N was spun on a glass subtract followed by conventional UV lithographic processes to fabricate the master to cast the PDMS elastomeric mold. A thin poly(vinyl alcohol) (PVA) layer was used as a mode release such that the PLA scaffold can be easily peeled off. The PLA precursor solution was then cast onto the PDMS mold to form the PLA microstructures. After evaporating the solvent, the PLA microstructures can be easily peeled off from the PDMS mold. Experimental results show that the desired microvessels scaffold can be successfully transferred to the biodegradable polymer PLA.Comment: Submitted on behalf of EDA Publishing Association (http://irevues.inist.fr/EDA-Publishing

Some New Concepts of Shape Memory Effect of Polymers

In this study some new concepts regarding certain aspects related to shape memory polymers are presented. A blend of polylactic acid (PLA) (80%) and polybutylene succinate (PBS) (20%) was prepared first by extrusion, then by injection molding to obtain the samples. Tensile, stress-relaxation and recovery tests were performed on these samples at 70 °C. The results indicated that the blend can only regain 24% of its initial shape. It was shown that, this partial shape memory effect could be improved by successive cycles of shape memory tests. After a fourth cycle, the blend is able to regain 82% of its shape. These original results indicated that a polymer without (or with partial) shape memory effect may be transformed into a shape memory polymer without any chemical modification. In this work, we have also shown the relationship between shape memory and property memory effect. Mono and multi-frequency DMA (dynamic mechanical analyzer) tests on virgin and 100% recovered samples of polyurethane (PU) revealed that the polymer at the end of the shape memory tests regains 100% of its initial form without regaining some of its physical properties like glass transition temperature, tensile modulus, heat expansion coefficient and free volume fraction. Shape memory (with and without stress-relaxation) tests were performed on the samples in order to show the role of residual stresses during recovery tests. On the basis of the results we have tried to show the origin of the driving force responsible for shape memory effect

Bioactive composites for bone tissue engineering

One of the major challenges of bone tissue engineering is the production of a suitable scaffold material. In this review the current composite materials options available are considered covering both the methods of both production and assessing the scaffolds. A range of production routes have been investigated ranging from the use of porogens to produce the porosity through to controlled deposition methods. The testing regimes have included mechanical testing of the materials produced through to in vivo testing of the scaffolds. While the ideal scaffold material has not yet been produced, progress is being made

Mechanical evaluation of polylactic acid (PLA) with nominal Hydroxyapatite filler for use in biomedical implants

Abstract only availableAn active area of research in the biomedical implant field is poly lactic acid (PLA). Polylactic acid is very interesting material for this field because it is a biocompatible and biodegradable material. One downside to using Polylactic acid PLA in biomedical implants is that it mechanical strength is much lower than that of its metal counterparts. However polylactic acid's many material attributes such as being biocompatibility and biodegradability make it a very promising and useful material if the mechanical properties were increased. In attempt to increase the bending strength of the Polylactic acid a Hydroxappatite filler was used. A mold was fabricated and samples were made using the heating press method. The samples were then test under three point bending to determines there bending strength using ASTM standard D5023-07. Pol lactic acid (PLA) was tested ranging from zero percent Hydroxyappattie filler to five percent Hydroxyappatite filler. Pure polylactic acid PLA was used as a base for comparisons. From these test to date the polylactic acid has shown a significant improvement in bending strength. This is a very promising result for polylactic acid's future in the biomedical field. Furthermore if it can be demonstrate that similar increases in bending strength in our polylactic acid samples can be demonstrated in actual bone screws or plates the increase in mechanical properties would have numerous implications for poly lactic acid in the biomedical field.MU Undergraduate Research Scholars Progra

Production, by co-grinding in a media mill, of porous biodegradable polylactic acid-apatite composite materials for bone tissue engineering

This paper presents the results of a study of the production of porous biodegradable composite materials by co-grinding, followed by scaffolding. Dry powders of polylactic acid and nanocrystalline carbonated apatite, analogous to bone mineral were co-ground in a tumbling ball mill in order to disperse the mineral filler within the polymer. Porous scaffolds were then made by hot moulding the mixture of the two components along with a pore-forming agent which was subsequently eliminated by washing. The mechanical resistance of the scaffolds was evaluated in order to determine the best operating conditions to produce implants offering optimised properties for use as bone substitutes. It was shown that 30 wt.% of filler and 70 wt.% of pore-forming agent produce scaffolds which are sufficiently porous and resistan